Top

Clinical Orthopaedics and Related Research®

Published in:

01-04-2017 | CORR Insights

CORR Insights^®: Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?

Author: Michelle Ghert, MD, FRCSC

Published in: Clinical Orthopaedics and Related Research® | Issue 4/2017

Excerpt

The development of novel targeted drugs, a renewed focus in immunotherapy, and improved symptom management have extended the life expectancy for a number of cancers [14]. Advancements in the systemic management of metastatic carcinoma can transform cancer into a chronic condition for some patients [1]. However, as life expectancies increase, we may see more patients with carcinomas who develop skeletal metastases, pathologic fractures, and spinal compression [4, 5, 15]. …

Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA, Debus J, Bischof M. Long-term survival of cancer patients compared to heart failure and stroke: A systematic review. BMC Cancer. 2010;10:105.CrossRefPubMedPubMedCentral

Bewick V, Cheek L, Ball J. Statistics review 13: Receiver operating characteristic curves. Crit Care. 2004;8:508–512.CrossRefPubMedPubMedCentral

Cannon CP, Mirza AN, Lin PP, Lewis VO, Yasko AW. Proximal femoral endoprosthesis for the treatment of metastatic. Orthopedics. 2008;31:361.CrossRefPubMed

Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–6249s.CrossRefPubMed

Delea T, Langer C, McKiernan J, Liss M, Edelsberg J, Brandman J, Sung J, Raut M, Oster G. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology. 2005;67:390–396.CrossRef

Deo RC. Machine learning in medicine. Circulation. 2015;132:1920–1930.CrossRefPubMed

Goh P, Harris K, Napolskikh J, Chow E, Sinclair E, Emmenegger U, Lemon S, Yee A, Wynnychuk L, Myers J, Danjoux C, Ko Y, Bone Metastases Site Group. New multidisciplinary prostate bone metastases clinic: First of its kind in Canada. Curr Oncol Tor Ont. 2007;14:9–12.CrossRef

Hong H, Carlin BP, Chu H, Shamliyan TA, Wang S, Kane RL. A Bayesian Missing Data Framework for Multiple Continuous Outcome Mixed Treatment Comparisons. Rockville, MD; Agency for Healthcare Research and Quality: 2013.

Janjan NA, Payne R, Gillis T, Podoloff D, Libshitz HI, Lenzi R, Theriault R, Martin C, Yasko A. Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manage. 1998;16:171–178.CrossRefPubMed

10.

Li KK, Sinclair E, Pope J, Farhadian M, Harris K, Napolskikh J, Yee A, Librach L, Wynnychuk L, Danjoux C, Chow E, Bone O behalf of the, Team M. A multidisciplinary bone metastases clinic at Toronto Sunnybrook Regional Cancer Centre – A review of the experience from 1999 to 2005. J Pain Res. 2008;1:43–48.

11.

Peterson JR, Villalobos CE, Zamora R, Wittig JC. Limb sparing resection for tumors involving the distal humerus and reconstruction with a modular endoprosthesis. Bull Hosp Jt Dis. 2015;73:190–197.

12.

Piccioli A, Spinelli MS, Forsberg JA, Wedin R, Healey JH, Ippolito V, Daolio PA, Ruggieri P, Maccauro G, Gasbarrini A, Biagini R, Piana R, Fazioli F, Luzzati A, Di Martino A, Nicolosi F, Camnasio F, Rosa MA, Campanacci DA, Denaro V, Capanna R. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations. BMC Cancer. 2015;15:424.CrossRefPubMedPubMedCentral

13.

Potter BK, Chow VE, Adams SC, Letson GD, Temple HT. Endoprosthetic proximal femur replacement: Metastatic versus primary tumors. Surg Oncol. 2009;18:343–349.CrossRefPubMed

14.

Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer. 2012;12:237–251.CrossRefPubMedPubMedCentral

15.

Weinfurt KP, Li Y, Castel LD, Saad F, Timbie JW, Glendenning GA, Schulman KA. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer. Ann Oncol. 2005;16:579–584.CrossRefPubMed

16.

Wood TJ, Racano A, Yeung H, Farrokhyar F, Ghert M, Deheshi BM. Surgical management of bone metastases: Quality of evidence and systematic review. Ann Surg Oncol. 2014;21:4081–4089.CrossRefPubMed

17.

Zhang J, Chu H, Hong H, Virnig BA, Carlin BP. Bayesian hierarchical models for network meta-analysis incorporating nonignorable missingness. Stat Methods Med Res. 2016; DOI: 10.1177/0962280215596185.

Title: CORR Insights®: Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
Author: Michelle Ghert, MD, FRCSC
Publication date: 01-04-2017
Publisher: Springer US
Published in: Clinical Orthopaedics and Related Research® / Issue 4/2017
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-016-5200-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

CORR Insights^®: Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2017

Lawnmowers Versus Children: The Devastation Continues

Reply to the Letter to the Editor: Not the Last Word: Safety Alert: One in 200 Knee Replacement Patients Die Within 90 Days of Surgery

CORR Insights®: Does Surgeon Experience Impact the Risk of Complications After Bernese Periacetabular Osteotomy?

From Bench to Bedside: Ischemia is Bad … Right?

Editor’s Spotlight/Take 5: Lawnmowers Versus Children: The Devastation Continues

Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?